Elevation of cortical serotonin transporter activity upon peripheral immune challenge is regulated independently of p38 mitogen‐activated protein kinase activation and transporter phosphorylation
Authors:
- 22 March 2016
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 137 (3) , 423-435
Abstract
The serotonin transporter (SERT) is responsible for high‐affinity serotonin (5‐HT) uptake from extracellular fluid and is a prominent pharmacological target in the treatment of depression. In recent years, depression has also been linked to immune system activation. Inflammatory conditions can cause sickness behaviour and depression‐like symptoms in both animals and humans. Since SERT has been proposed as one of the molecular targets in inflammation‐induced depression, we applied the widely used lipopolysaccharides (LPS) model to study the effects of peripheral inflammation on SERT activity in the brain. We show that 24 h after intraperitoneal LPS administration, SERT‐mediated 5‐HT uptake is significantly enhanced in the frontal cortex. Analysis of uptake kinetics revealed that the transport capacity (Vmax) of cortical SERT was increased in LPS‐injected animals, while the Km value remained unchanged. The increase in Vmax was neither due to increased SERT protein expression nor increased synaptic surface exposure. The suppression of SERT activity upon inhibition of p38 MAPK was not selective for LPS‐induced enhancement of SERT function. In addition, SERT activity changes in LPS‐treated rats are unaffected by nitric oxide synthase and protein kinase G inhibitors. Using the Phos‐Tag method, we identified five SERT‐specific protein bands representing distinct phosphorylation states of SERT. However, the enhancement of SERT activity in LPS‐treated rats was not correlated with altered transporter phosphorylation. Together with previous studies by others, our results suggest that SERT is regulated by multiple mechanisms in response to peripheral immune system activation. image Peripheral injection of lipopolysaccharide (LPS) induces characteristic sickness and depression‐like behaviour in rats over a period of at least 24 h. We show here that the activity of the serotonin transporter (SERT), a prominent antidepressant target, is up‐regulated 24 h following LPS administration. In contrast to previous studies focusing on earlier responses to LPS treatment, we found that SERT function is selectively enhanced in the frontal cortex, independently of the p38 MAPK pathway. Our study provides further insight into molecular mechanisms underlying inflammation‐induced depression.Keywords
Funding Information
- Health Research Board Ireland (HRA2009/303)
- Programme for Research in Third-Level Institutions
- European Regional Development Fund
This publication has 52 references indexed in Scilit:
- Serotonin and Prefrontal Cortex Function: Neurons, Networks, and CircuitsMolecular Neurobiology, 2011
- The contribution of low‐affinity transport mechanisms to serotonin clearance in synaptosomesSynapse, 2011
- Regulation of monoamine transporters: Role of transporter phosphorylationPharmacology & Therapeutics, 2011
- 5-HT and the immune systemCurrent Opinion in Pharmacology, 2011
- The functional neuroanatomy of depression: Distinct roles for ventromedial and dorsolateral prefrontal cortexBehavioural Brain Research, 2009
- Unfaithful neurotransmitter transporters: Focus on serotonin uptake and implications for antidepressant efficacyPharmacology & Therapeutics, 2009
- How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systemsNeuropharmacology, 2008
- Spatio-temporal differences in the profile of murine brain expression of proinflammatory cytokines and indoleamine 2,3-dioxygenase in response to peripheral lipopolysaccharide administrationJournal of Neuroimmunology, 2008
- From inflammation to sickness and depression: when the immune system subjugates the brainNature Reviews Neuroscience, 2008
- Effects of cytokines and infections on brain neurochemistryClinical Neuroscience Research, 2006